ArticleBioengineering (Basel, Switzerland)2024
Edge-AI Enabled Wearable Device for Non-Invasive Type 1 Diabetes Detection Using ECG Signals.
Article in Bioengineering (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Effectiveness of Wearable Devices for Diabetes Management: An Overview of Systematic Reviews and Meta-Analyses.Journal of diabetes research · 2026Pooled it
- Design and Systematic Evaluation of a Multi-Layered Mattress System for Accurate, Unobtrusive Capacitive ECG Monitoring.Bioengineering (Basel, Switzerland) · 2025Article
- An Edge AI Approach for Low-Power, Real-Time Atrial Fibrillation Detection on Wearable Devices Based on Heartbeat Intervals.Sensors (Basel, Switzerland) · 2025Article
- From Innovation to Integration: Bridging the Gap Between IoMT Technologies and Real-World Health Management Systems.Sensors (Basel, Switzerland) · 2025Article
- Artificial Intelligence-Assisted Nanosensors for Clinical Diagnostics: Current Advances and Future Prospects.Biosensors · 2025Review
- An Effective Methodology for Diabetes Prediction in the Case of Class Imbalance.Bioengineering (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Diabetes is a chronic condition, and traditional monitoring methods are invasive, significantly reducing the quality of life of the patients. This study proposes the design of an innovative system based on a microcontroller that performs real-time ECG acquisition and evaluates the presence of diabetes using an Edge-AI solution. A spectrogram-based preprocessing method is combined with a 1-Dimensional Convolutional Neural Network (1D-CNN) to analyze the ECG signals directly on the device. By applying quantization as an optimization technique, the model effectively balances memory usage and accuracy, achieving an accuracy of 89.52% with an average precision and recall of 0.91 and 0.90, respectively. These results were obtained with a minimal memory footprint of 347 kB flash and 23 kB RAM, showcasing the system's suitability for wearable embedded devices. Furthermore, a custom PCB was developed to validate the system in a real-world scenario. The hardware integrates high-performance electronics with low power consumption, demonstrating the feasibility of deploying Edge-AI for non-invasive, real-time diabetes detection in resource-constrained environments. This design represents a significant step forward in improving the accessibility and practicality of diabetes monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.